查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553686

北美OTC透明質酸市場規模、佔有率和趨勢分析報告：按產品、銷售管道、國家、細分市場預測，2024-2030年

North America OTC Hyaluronic Acid Market Size, Share & Trends Analysis Report By Product (Dermatology (Moisturizers), Orthopedics), By Sales Channel (Online, Retail), By Country, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

北美OTC透明質酸市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，北美OTC透明質酸市場規模將達到102.9億美元，預測期內複合年成長率為7.9%。

造成這一成長的因素之一是由於缺乏運動而導致肥胖人數增加、速食和酒精消費量增加，尤其是年輕人數量增加。

透明質酸 (HA) 的整形外科應用預計將成為該市場中最有利可圖的領域。這是由於越來越多的針對 60 歲以上患有類風濕性關節炎和骨關節炎等各種關節疾病的人群，以及針對這一人群的新產品的推出。此外，由於關節炎相關住院人數的增加以及醫療保健專業人員對透明質酸卓越理化特性的認知不斷提高，預計需求將受到推動。 20 至 65 歲之間的女性人口不斷增加，以及人們對透明質酸益處的認知不斷提高，是推動皮膚科手術中透明質酸需求激增的關鍵因素。

透明質酸 (HA) 刺激蛋白質的合成，這些蛋白質在支持皮膚結構和膠原蛋白發揮重要作用。對透明質酸作為外用護膚霜和精華液的需求不斷成長，加上該領域的市場參與企業不斷增加，預示著未來的成長。人們對護膚品中透明質酸的益處的認知不斷提高，與膠原蛋白相比，透明質酸更能有效地滲透真皮，預計也將推動市場趨勢。根據多方報道，美國女性總人口中約27%屬於45歲至65歲年齡段，是抗皺霜需求激增的關鍵因素之一。

主要參與者包括資生堂、Lindberg Nutrition &GeniusCentral Systems、Nature's Way Products, LLC、NOW Foods、NeoCell Corporation、Source Naturals, Inc、Doctors Best、derma e 和 Earth Science Naturals。

北美非處方透明質酸市場報告亮點：

  • 按產品分類，皮膚科細分市場在 2023 年佔據最大的市場收益佔有率。該細分市場的快速成長是由於各種手術中對透明質酸填充劑的需求激增以及皺紋、痤瘡和疤痕等皮膚問題病例的增加而推動的。
  • 由於肌肉骨骼疾病、運動傷害和骨折的增加，整形外科預計將在預測期內實現最快的成長。
  • 以銷售管道來看，零售佔最大市場收益佔有率，2023年將達83.7%。預計推動市場的主要因素是在藥局、百貨公司和超級市場容易買到化妝品和聯合補充品。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章北美OTC透明質酸市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 北美OTC透明質酸市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 北美OTC透明質酸市場：依產品估算及趨勢分析

  • 細分儀表板
  • 北美非處方透明質酸市場：2023 年和 2030 年產品變化分析
  • 皮膚科
  • 整形外科

第5章 北美OTC玻尿酸市場：依銷售管道估算及趨勢分析

  • 細分儀表板
  • 北美OTC透明質酸市場：2023年及2030年銷售管道波動分析
  • 零售
  • 線上

第6章 北美OTC玻尿酸市場：區域預估及趨勢分析

  • 2023 年和 2030 年北美非處方透明質酸市場佔有率（按國家/地區）
  • 美國
    • 加州
    • 德克薩斯
    • 紐約
    • 佛羅裡達
    • 其他州
  • 加拿大
  • 墨西哥

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Shiseido Company
    • Lindberg Nutrition Products
    • Nature's Way
    • Now Foods
    • NeoCell Corporation
    • Source Naturals, Inc.
    • Doctor's Best
    • Derma E
    • Earth Science
簡介目錄
Product Code: GVR-1-68038-435-2

North America OTC Hyaluronic Acid Market Growth & Trends:

The North America OTC hyaluronic acid market size is expected to reach USD 10.29 billion by 2030, registering a CAGR of 7.9% during the forecast period, according to a new report by Grand View Research, Inc. The increasing number of obese people owing to the lack of physical activity and higher consumption of fast food & alcohol, especially by the younger population are some of the factors accounting for growth.

Orthopedic applications of hyaluronic acid (HA) are expected to emerge as the most lucrative segment of this market. This can be attributed to the growing target audience above 60 years, suffering from various joint disorders such as rheumatoid arthritis and osteoarthritis coupled with the introduction of new products catering to this population subset. In addition, an increase in the number of arthritis-related hospitalization cases and growing awareness amongst the healthcare professionals regarding excellent physiochemical properties of hyaluronic acid is expected to drive the demand. The growing population of women between 20 and 65 years of age and increasing awareness regarding the benefits of HA is some of the crucial factors driving the surging demand for hyaluronic acid in dermatological procedures.

Hyaluronic acid (HA) stimulates the synthesis of a protein that plays a crucial role in supporting skin structure and collagen, which declines with age leading to wrinkling formation. The growing demand for HA as a topical skin cream or serum coupled with the increasing presence of market participants in this sector is indicative of future growth. The rising awareness regarding the benefits of HA in skincare products for penetrating the dermis more effectively as compared to collagen is also anticipated to propel the market trend. According to various reports, approximately 27% of the total U.S. women population belong to the age group of 45 to 65 years, which is one of the crucial factors responsible for the surging demand for anti-wrinkle creams.

Some of the key players are Shiseido Co., Ltd.; Lindberg Nutrition & GeniusCentral Systems; Nature's Way Products, LLC; NOW Foods; NeoCell Corporation; Source Naturals, Inc.; Doctors Best; derma e; and Earth Science Naturals.

North America OTC Hyaluronic Acid Market Report Highlights:

  • By product, Dermatology segment accounted for the largest market revenue share in 2023. The rapid growth of this segment is being fueled by a surge in demand for HA-based fillers for various procedures, as well as a rise in cases of skin concerns such as wrinkles, acne, and scarring.
  • Orthopedics is expected to register the fastest growth during the forecast period, driven by the rise of musculoskeletal disorders, sports injuries, and fractures.
  • By sales channel, retail accounted for the largest market revenue share of 83.7% in 2023. Main factors that is anticipated to drive the market is the easy access to cosmetics and joint supplements in drug stores, departmental stores, and supermarkets.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. North America OTC Hyaluronic Acid Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. North America OTC Hyaluronic Acid Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. North America OTC Hyaluronic Acid Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. North America OTC Hyaluronic Acid Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Dermatology
    • 4.3.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Moisturizers
      • 4.3.2.1. Moisturizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Anti-wrinkle Creme
      • 4.3.3.1. Anti-wrinkle Creme Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Orthopedics
    • 4.4.1. Orthopedics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America OTC Hyaluronic Acid Market: Sales Channel Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. North America OTC Hyaluronic Acid Market: Sales Channel Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Retail
    • 5.3.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Online
    • 5.4.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America OTC Hyaluronic Acid Market: Regional Estimates & Trend Analysis

  • 6.1. North America OTC Hyaluronic Acid Market Share, By Country, 2023 & 2030 (USD Million)
  • 6.2. U.S.
    • 6.2.1. U.S. OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. California
      • 6.2.2.1. California OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Texas
      • 6.2.3.1. Texas OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. New York
      • 6.2.4.1. New York OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.5. Florida
      • 6.2.5.1. Florida OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.6. Other States
      • 6.2.6.1. Other States OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Canada
    • 6.3.1. Canada North America OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Mexico
    • 6.4.1. Mexico North America OTC Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Shiseido Company
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. Lindberg Nutrition Products
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. Nature's Way
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. Now Foods
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. NeoCell Corporation
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. Source Naturals, Inc.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. Doctor's Best
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. Derma E
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. Earth Science
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives